Behbahani Ali

CIK 000161386722 companiesTIMONIUM, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001613867

Recent Transactions

50 trades

Sale
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−280→ 787,979 total
Sale
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−280→ 488,702 total
Award
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02+372,255→ 372,255 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+607,536→ 2,261,870 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+124,085→ 2,385,055 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−1,656,789→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+189,195→ 788,259 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series A Convertible Perpetual Preferred Stock
2025-10-02−125,000→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−189,195→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+189,195→ 488,982 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−372,255→ 0 total
Sale
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−2,455→ 1,654,334 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+1,656,789→ 1,656,789 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−607,536→ 0 total
Tax Payment
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−182→ 2,384,873 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series B Convertible Perpetual Preferred Stock
2025-10-02−100,000→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−124,085→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−189,195→ 0 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02−1,159,683→ 0 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series A Convertible Perpetual Preferred Stock
2025-10-02−75,000→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−186,128→ 0 total
Tax Payment
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−276→ 674,554 total
Award
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02+124,085→ 124,085 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+186,128→ 674,830 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series B Convertible Perpetual Preferred Stock
2025-10-02−37,700→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+372,255→ 1,160,234 total
Sale
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−900→ 2,260,970 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02−2,384,873→ 0 total
Tax Payment
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−551→ 1,159,683 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02−674,554→ 0 total
Award
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02+186,128→ 186,128 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2025-09-19$3.35/sh+4,291→ 81,441 total
Sale
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2025-08-18$0.01/sh−14,671,794→ 0 total
Sale
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2025-08-15$0.01/sh−4,828,206→ 14,671,794 total
Other
Arcellx, Inc.$ACLX
Common Stock
2025-08-12+2,621→ 2,706 total
Other
Arcellx, Inc.$ACLX
Common Stock
2025-08-12+1,586→ 1,925 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2025-06-20$2.33/sh+6,170→ 77,150 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2025-06-13+30,700→ 30,700 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2025-06-12+30,550→ 30,550 total
Award
Korro Bio, Inc.$KRRO
Stock Option (Right to Buy)
2025-06-11+6,010→ 6,010 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-06-05+13,000→ 13,000 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2025-06-05+46,000→ 46,000 total
Award
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2025-05-29+9,174→ 9,174 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2025-03-21$1.88/sh+7,646→ 70,980 total
Purchase
Marker Therapeutics, Inc.$MRKR
Common Stock
2024-12-23$3.20/sh+554,250→ 1,625,678 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2024-12-13$2.50/sh+5,750→ 63,334 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-10-01+61,865→ 185,594 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-10-01+185,595→ 556,782 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-10-01+61,865→ 185,594 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2024-09-20$4.78/sh+3,007→ 57,584 total

Recent Filings

4
Behbahani Ali
Oct 6, 2025

Address

1954 GREENSPRING DRIVE, SUITE 600

TIMONIUM, MD, 21093

View on SEC.gov